|
Jun 14
|
Champions Oncology, Inc.'s (NASDAQ:CSBR) 11% gain last week benefited both private equity firms who own 30% as well as insiders
|
|
Feb 18
|
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting
|
|
Jan 9
|
Champions Oncology integrates Cytek Aurora flow cytometers
|
|
Jan 8
|
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership
|